tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AZN Stock Latest News

AstraZeneca’s iCaReMe Global Registry: A Real-World Study on Chronic Disease Management
Company AnnouncementsAstraZeneca’s iCaReMe Global Registry: A Real-World Study on Chronic Disease Management
4h ago
AZN
AstraZeneca’s New Study on CRT Patterns in Russia: A Potential Game-Changer for Lung Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s New Study on CRT Patterns in Russia: A Potential Game-Changer for Lung Cancer Treatment
4h ago
AZN
AstraZeneca’s CKD Registry Study: A Strategic Move in Nephrology
PremiumCompany Announcements
AstraZeneca’s CKD Registry Study: A Strategic Move in Nephrology
4h ago
AZN
AstraZeneca’s Real-World Study on Tezepelumab: A Potential Game-Changer for Severe Asthma
PremiumCompany Announcements
AstraZeneca’s Real-World Study on Tezepelumab: A Potential Game-Changer for Severe Asthma
4h ago
AZN
AstraZeneca’s Phase I Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Phase I Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
4h ago
AZN
PRXL
AstraZeneca’s Phase III Breast Cancer Study: A Potential Game Changer?
PremiumCompany AnnouncementsAstraZeneca’s Phase III Breast Cancer Study: A Potential Game Changer?
4h ago
AZN
AstraZeneca’s Phase 3 Study on Anifrolumab for Systemic Lupus Erythematosus: A Market Game Changer?
Premium
Company Announcements
AstraZeneca’s Phase 3 Study on Anifrolumab for Systemic Lupus Erythematosus: A Market Game Changer?
4h ago
AZN
AstraZeneca’s Phase III Study: Baxdrostat and Dapagliflozin Combination for Heart Failure Prevention
Premium
Company Announcements
AstraZeneca’s Phase III Study: Baxdrostat and Dapagliflozin Combination for Heart Failure Prevention
4h ago
AZN
AstraZeneca’s New Study on AZD0305: Potential Breakthrough in Multiple Myeloma Treatment?
PremiumCompany Announcements
AstraZeneca’s New Study on AZD0305: Potential Breakthrough in Multiple Myeloma Treatment?
4h ago
AZN
AstraZeneca’s ROSY-D Study: Extending Benefits of Durvalumab in Oncology
PremiumCompany Announcements
AstraZeneca’s ROSY-D Study: Extending Benefits of Durvalumab in Oncology
4h ago
AZN
Amgen and AstraZeneca’s New Study on Tarlatamab for Lung Cancer: Key Insights for Investors
PremiumCompany Announcements
Amgen and AstraZeneca’s New Study on Tarlatamab for Lung Cancer: Key Insights for Investors
4h ago
AZN
AMGN
AstraZeneca’s Observational Study on Bladder Cancer Biomarkers in Russia: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca’s Observational Study on Bladder Cancer Biomarkers in Russia: Key Insights for Investors
4h ago
AZN
AstraZeneca’s Pediatric Hyperkalaemia Study: A Potential Market Game-Changer
PremiumCompany AnnouncementsAstraZeneca’s Pediatric Hyperkalaemia Study: A Potential Market Game-Changer
4h ago
AZN
AstraZeneca Completes Key Study on Lynparza’s Real-World Impact
Premium
Company Announcements
AstraZeneca Completes Key Study on Lynparza’s Real-World Impact
4h ago
AZN
AstraZeneca’s Innovative CAR T Therapy Study for Refractory SLE: A Market Game-Changer?
Premium
Company Announcements
AstraZeneca’s Innovative CAR T Therapy Study for Refractory SLE: A Market Game-Changer?
4h ago
AZN
AstraZeneca’s New Study on Endometrial Cancer: Market Implications and Study Insights
PremiumCompany Announcements
AstraZeneca’s New Study on Endometrial Cancer: Market Implications and Study Insights
4h ago
AZN
AstraZeneca’s Phase I Study on AZD6244: Implications for Advanced Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s Phase I Study on AZD6244: Implications for Advanced Cancer Treatment
4h ago
AZN
AstraZeneca’s Promising Phase 3 Study on Mantle Cell Lymphoma Treatment
PremiumCompany Announcements
AstraZeneca’s Promising Phase 3 Study on Mantle Cell Lymphoma Treatment
4h ago
AZN
AstraZeneca and Bayer’s Promising Prostate Cancer Study: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca and Bayer’s Promising Prostate Cancer Study: Key Insights for Investors
4h ago
AZN
AstraZeneca’s Real-World Study on Dapagliflozin: Implications for Heart Failure Treatment
PremiumCompany AnnouncementsAstraZeneca’s Real-World Study on Dapagliflozin: Implications for Heart Failure Treatment
4h ago
AZN
AstraZeneca Completes Phase 2a Study on Liver Fibrosis Treatment AZD2389
Premium
Company Announcements
AstraZeneca Completes Phase 2a Study on Liver Fibrosis Treatment AZD2389
5h ago
AZN
AstraZeneca’s Promising Study on Durvalumab and Olaparib in Advanced Bladder Cancer
Premium
Company Announcements
AstraZeneca’s Promising Study on Durvalumab and Olaparib in Advanced Bladder Cancer
5h ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >